Patent applications and USPTO patent grants for MEDIVIR AB.The latest application filed is for "methods for treating liver cancers using an orally administered dioxolane nucleotide in combination with an anti-pd1 or anti-pdl1 monoclonal antibody".
Patent | Date |
---|---|
Dioxolane analogues of uridine for the treatment of cancer Grant 11,447,511 - Bethell , et al. September 20, 2 | 2022-09-20 |
SMAC mimetic Grant 11,351,221 - Condon , et al. June 7, 2 | 2022-06-07 |
Protease inhibitors Grant 11,312,693 - Oden , et al. April 26, 2 | 2022-04-26 |
Methods For Treating Liver Cancers Using An Orally Administered Dioxolane Nucleotide In Combination With An Anti-pd1 Or Anti-pdl1 Monoclonal Antibody App 20220117983 - ALBERTELLA; Mark | 2022-04-21 |
Base-Modified Cytidine Nucleotides for Leukemia Therapy App 20210261584 - PINHO; Pedro ;   et al. | 2021-08-26 |
Dioxolane Analogues Of Uridine For The Treatment Of Cancer App 20210054008 - BETHELL; Richard ;   et al. | 2021-02-25 |
Pharmaceutical Formulation for Histone Deacetylase Inhibitors App 20210038555 - Chappell; Todd W. ;   et al. | 2021-02-11 |
Protease Inhibitors App 20210017140 - ODEN; Lourdes Salvador ;   et al. | 2021-01-21 |
Cancer Treatment With (2,2-bishydroxymethyl) Methylenecyclopropane Nucleotides App 20200399295 - KLASSON; Bjorn ;   et al. | 2020-12-24 |
Dioxolane analogues of uridine for the treatment of cancer Grant 10,822,360 - Bethell , et al. November 3, 2 | 2020-11-03 |
SMAC Mimetic App 20200282002 - Condon; Stephen M. ;   et al. | 2020-09-10 |
Dioxolane Analogues Of Uridine For The Treatment Of Cancer App 20200239502 - BETHELL; Richard ;   et al. | 2020-07-30 |
Protease inhibitors Grant 10,723,709 - Oden , et al. | 2020-07-28 |
Dioxolane analogues of uridine for the treatment of cancer Grant 10,654,877 - Bethell , et al. | 2020-05-19 |
SMAC mimetic Grant 10,596,220 - Condon , et al. | 2020-03-24 |
Therapeutic Applications Of Malt1 Inhibitors App 20200009135 - ALBERTELLA; Mark ;   et al. | 2020-01-09 |
Protease Inhibitors App 20200010434 - ODEN; Lourdes Salvador ;   et al. | 2020-01-09 |
Dioxolane Analogues Of Uridine For The Treatment Of Cancer App 20190389890 - BETHELL; Richard ;   et al. | 2019-12-26 |
SMAC Mimetic App 20190255139 - Condon; Stephen M. ;   et al. | 2019-08-22 |
Dioxolane analogues of uridine for the treatment of cancer Grant 10,336,780 - Bethell , et al. | 2019-07-02 |
Protease inhibitors Grant 10,329,266 - Oden , et al. | 2019-06-25 |
Pharmaceutical Formulation for Histone Deacetylase Inhibitors App 20190175539 - Chappell; Todd W. ;   et al. | 2019-06-13 |
SMAC mimetic Grant 10,314,881 - Condon , et al. | 2019-06-11 |
Pharmaceutical formulation for histone deacetylase inhibitors Grant 10,258,595 - Chappell , et al. | 2019-04-16 |
Dioxolane Analogues Of Uridine For The Treatment Of Cancer App 20190100541 - BETHELL; Richard ;   et al. | 2019-04-04 |
Hcv Polymerase Inhibitors App 20190085010 - KALAYANOV; Genadiy ;   et al. | 2019-03-21 |
HCV NS-3 serine protease inhibitors Grant 10,172,846 - Rosenquist , et al. J | 2019-01-08 |
Respiratory Syncytial Virus Inhibitors App 20190002436 - AYESA; Susana ;   et al. | 2019-01-03 |
Dioxolane analogues of cytidine for the treatment of cancer Grant 10,144,750 - Bethell , et al. De | 2018-12-04 |
Protease Inhibitors App 20180327371 - ODEN; Lourdes Salvador ;   et al. | 2018-11-15 |
Methods for the preparation of diastereomerically pure phosphoramidate prodrugs Grant 10,118,941 - Pinho , et al. November 6, 2 | 2018-11-06 |
HCV polymerase inhibitors Grant 10,106,571 - Kalayanov , et al. October 23, 2 | 2018-10-23 |
Hcv Polymerase Inhibitors App 20180105549 - KALAYANOV; Genadiy ;   et al. | 2018-04-19 |
Nucleotide Phosphoramidate Formulation App 20180036330 - ANDERSSON; Mattias | 2018-02-08 |
Macrocyclic inhibitors of hepatitis C virus Grant 9,856,265 - Simmen , et al. January 2, 2 | 2018-01-02 |
HCV polymerase inhibitors Grant 9,828,408 - Kalayanov , et al. November 28, 2 | 2017-11-28 |
Protease Inhibitors App 20170334867 - ODEN; Lourdes Salvador ;   et al. | 2017-11-23 |
Methods For The Preparation Of Diastereomerically Pure Phosphoramidate Prodrugs App 20170275322 - PINHO; Pedro ;   et al. | 2017-09-28 |
Dioxolane Analogues Of Uridine For The Treatment Of Cancer App 20170267705 - BETHEL; Richard ;   et al. | 2017-09-21 |
Macrocyclic Inhibitors Of Hepatitis C Virus App 20170226111 - Simmen; Kenneth Alan ;   et al. | 2017-08-10 |
Respiratory syncytial virus inhibitors Grant 9,708,332 - Sturino , et al. July 18, 2 | 2017-07-18 |
Hcv Ns-3 Serine Protease Inhibitors App 20170196849 - Rosenquist; Asa ;   et al. | 2017-07-13 |
Protease Inhibitors App 20170166538 - ODEN; Lourdes Salvador ;   et al. | 2017-06-15 |
Form 2 crystalline polymorph of a salt of N-[1-6-(ethynyl-3-oxo-hexahydro-furo[3,2-B]pyrrole-4-carbonyl)-3-methyl-b- utyl]-4-[5-fluoro-2-(4-methyl-piperazinyl) thiazol-4-yl]-benzamide useful as cysteine protease inhibitor Grant 9,650,388 - Grabowska , et al. May 16, 2 | 2017-05-16 |
Treatment Of Chagas Disease App 20170114029 - KAHNBERG; Pia ;   et al. | 2017-04-27 |
Hcv Polymerase Inhibitors App 20170107244 - KALAYANOV; Genadiy ;   et al. | 2017-04-20 |
Macrocyclic inhibitors of hepatitis C virus Grant 9,623,022 - Simmen , et al. April 18, 2 | 2017-04-18 |
HCV polymerase inhibitors Grant 9,540,411 - Kalayanov , et al. January 10, 2 | 2017-01-10 |
Hcv Polymerase Inhibitors App 20160340380 - KALAYANOV; Genadiy ;   et al. | 2016-11-24 |
HCV polymerase inhibitors Grant 9,481,703 - Kalayanov , et al. November 1, 2 | 2016-11-01 |
Hcv Polymerase Inhibitors App 20160271160 - KALAYANOV; Genadiy ;   et al. | 2016-09-22 |
Respiratory Syncytial Virus Inhibitors App 20160272646 - STURINO; Claudio ;   et al. | 2016-09-22 |
Protease inhibitors Grant 9,428,517 - Oden , et al. August 30, 2 | 2016-08-30 |
Macrocyclic Inhibitors Of Hepatitis C Virus App 20160235737 - Simmen; Kenneth Alan ;   et al. | 2016-08-18 |
Form 2 Crystalline Polymorph Of A Salt Of N-[1-6-(ethynyl-3-oxo-hexahydro-furo[3,2-b]pyrrole-4-carbonyl)-3-methyl-b- Utyl]-4-[5-fluoro-2-(4-methyl-piperazinyl)thiazol-4-yl]-benzamide Useful As Cysteine Protease Inhibitor App 20160194334 - GRABOWSKA; Urszula ;   et al. | 2016-07-07 |
Macrocyclic inhibitors of hepatitis C virus Grant 9,353,103 - Simmen , et al. May 31, 2 | 2016-05-31 |
Protease Inhibitors App 20160068539 - ODEN; Lourdes Salvador ;   et al. | 2016-03-10 |
Protease inhibitors Grant 9,200,006 - Oden , et al. December 1, 2 | 2015-12-01 |
Macrocyclic Inhibitors Of Hepatitis C Virus App 20150218153 - Simmen; Kenneth Alan ;   et al. | 2015-08-06 |
Hcv Polymerase Inhibitors App 20150175648 - KALAYANOV; Genadiy ;   et al. | 2015-06-25 |
Macrocyclic inhibitors of hepatitis C virus Grant 9,040,562 - Simmen , et al. May 26, 2 | 2015-05-26 |
Macrocyclic inhibitors of hepatitis C virus Grant 9,023,808 - Simmen , et al. May 5, 2 | 2015-05-05 |
Uracyl spirooxetane nucleoside phosphoramidates Grant 9,012,428 - Jonckers , et al. April 21, 2 | 2015-04-21 |
Uracyl spirooxetane nucleoside phosphoramidates Grant 9,006,209 - Jonckers , et al. April 14, 2 | 2015-04-14 |
Pyrimidine substituted macrocyclic HCV inhibitors Grant 8,937,080 - Raboisson , et al. January 20, 2 | 2015-01-20 |
Uracyl spirooxetane nucleosides Grant 8,933,052 - Jonckers , et al. January 13, 2 | 2015-01-13 |
Macrocyclic Inhibitors Of Hepatitis C Virus App 20140255347 - Simmen; Kenneth Alan ;   et al. | 2014-09-11 |
Protease Inhibitors App 20140221654 - ODEN; Lourdes Salvador ;   et al. | 2014-08-07 |
Macrocyclic inhibitors of hepatitis C virus Grant 8,754,105 - Simmen , et al. June 17, 2 | 2014-06-17 |
Macrocyclic inhibitors of hepatitis C virus Grant 8,754,106 - Simmen , et al. June 17, 2 | 2014-06-17 |
Macrocyclic inhibitors of hepatitis C virus Grant 8,741,926 - Simmen , et al. June 3, 2 | 2014-06-03 |
Protease inhibitors Grant 8,735,395 - Oden , et al. May 27, 2 | 2014-05-27 |
Hcv Polymerase Inhibitors App 20140066398 - ENEROTH; Anders ;   et al. | 2014-03-06 |
Phosphoramidate derivatives of nucleosides Grant 8,552,021 - Jonckers , et al. October 8, 2 | 2013-10-08 |
Protease Inhibitors App 20130231349 - ODEN; Lourdes Salvador ;   et al. | 2013-09-05 |
Combination Of Alovudine And Zidovudine In A Molar Ratio Of 1:100 To 1:350 App 20130217646 - ZHANG; Hong ;   et al. | 2013-08-22 |
Macrocyclic Inhibitors Of Hepatitis C Virus App 20130217725 - Simmen; Kenneth Alan ;   et al. | 2013-08-22 |
Uracyl Spirooxetane Nucleosides App 20130217648 - Jonckers; Tim Hugo Maria ;   et al. | 2013-08-22 |
Uracyl spirooxetane nucleosides Grant 8,481,510 - Jonckers , et al. July 9, 2 | 2013-07-09 |
Cysteine protease inhibitors Grant 8,466,158 - Nilsson , et al. June 18, 2 | 2013-06-18 |
HCV Polymerase Inhibitors App 20130143835 - ENEROTH; Anders ;   et al. | 2013-06-06 |
Cyclopropyl polymerase inhibitors Grant 8,431,588 - Jonckers , et al. April 30, 2 | 2013-04-30 |
Protease inhibitors Grant 8,426,421 - Oden , et al. April 23, 2 | 2013-04-23 |
Macrocyclic Inhibitors Of Hepatitis C Virus App 20130089520 - Simmen; Kenneth Alan ;   et al. | 2013-04-11 |
Uracyl cyclopropyl nucleotides Grant 8,399,429 - Jonckers , et al. March 19, 2 | 2013-03-19 |
HCV inhibiting macrocyclic phenylcarbamates Grant 8,383,584 - Antonov , et al. February 26, 2 | 2013-02-26 |
Combination of a Macrocyclic Inhibitor of HCV, A Non-Nucleoside and a Nucleoside App 20130028865 - Lin; Tse-I ;   et al. | 2013-01-31 |
Macrocylic inhibitors of hepatitis C virus Grant 8,349,869 - Simmen , et al. January 8, 2 | 2013-01-08 |
(2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors Grant 8,338,471 - Wallberg , et al. December 25, 2 | 2012-12-25 |
Protease Inhibitors App 20120289519 - ODEN; Lourdes Salvador ;   et al. | 2012-11-15 |
Phosphoramidate Derivatives of Nucleosides App 20120225839 - Jonckers; Tim Hugo Maria ;   et al. | 2012-09-06 |
Cysteine Protease Inhibitors App 20120220602 - Nilsson; Magnus ;   et al. | 2012-08-30 |
Protease inhibitors Grant 8,242,119 - Oden , et al. August 14, 2 | 2012-08-14 |
Macrocyclic inhibitors of hepatitis C virus Grant 8,227,407 - Simmen , et al. July 24, 2 | 2012-07-24 |
Cysteine protease inhibitors Grant 8,198,283 - Nilsson , et al. June 12, 2 | 2012-06-12 |
Acyclic Nucleoside Derivatives App 20120123119 - ENGELHARDT; Per ;   et al. | 2012-05-17 |
Combination Of Alovudine And Zidovudine In A Molar Ratio Of 1:100 To 1:350 App 20120115807 - ZHANG; Hong ;   et al. | 2012-05-10 |
Antiviral nucleosides Grant 8,158,779 - Johansson , et al. April 17, 2 | 2012-04-17 |
1-[2', 3' -dideoxy-3' C- (hydroxymethyl)--beta-D-erythro-pentofuranosyl] cytosine derivatives as HIV inhibitors Grant 8,143,396 - Zhou , et al. March 27, 2 | 2012-03-27 |
Acyclic nucleoside derivatives Grant 8,124,609 - Engelhardt , et al. February 28, 2 | 2012-02-28 |
(2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides As Metalloproteinase Inhibitors App 20120015994 - WALLBERG; Hans ;   et al. | 2012-01-19 |
(2,5-dioxoimidazolidin-1-yl)-N-hydroxy-acetamides as metalloproteinase inhibitors Grant 8,022,092 - Wallberg , et al. September 20, 2 | 2011-09-20 |
Dutpase inhibitors Grant 8,017,620 - Gilbert , et al. September 13, 2 | 2011-09-13 |
Macrocyclic inhibitors of hepatitis C virus Grant 8,012,939 - Simmen , et al. September 6, 2 | 2011-09-06 |
Macrocyclic inhibitors of hepatitis C virus Grant 8,008,251 - Simmen , et al. August 30, 2 | 2011-08-30 |
Antiviral Nucleosides App 20110172410 - JOHANSSON; Nils-Gunnar ;   et al. | 2011-07-14 |
Cysteine Protease Inhibitors App 20110112089 - NILSSON; Magnus ;   et al. | 2011-05-12 |
1-[2', 3' -dideoxy-3' C- (hydroxymethyl) - Beta-d-erythro-pentofuranosyl] Cytosine Derivatives As Hiv Inhibitors App 20110112294 - ZHOU; Xiao-Xiong ;   et al. | 2011-05-12 |
Cysteine Protease Inhibitors App 20110105524 - NILSSON; Magnus ;   et al. | 2011-05-05 |
Antiviral nucleosides Grant 7,935,681 - Johansson , et al. May 3, 2 | 2011-05-03 |
Cysteine protease inhibitors Grant 7,915,300 - Nilsson , et al. March 29, 2 | 2011-03-29 |
Non-nucleotide reverse transcriptase inhibitors Grant 7,915,295 - Sund , et al. March 29, 2 | 2011-03-29 |
Cysteine protease inhibitors Grant 7,893,067 - Nilsson , et al. February 22, 2 | 2011-02-22 |
Protease Inhibitors App 20110039862 - Oden; Lourdes Salvadore ;   et al. | 2011-02-17 |
1-[2',3' -dideoxy-3' C-(hydroxymethyl)--beta-D-erythro-pentofuranosyl] cytosine derivatives as HIV Grant 7,888,367 - Zhou , et al. February 15, 2 | 2011-02-15 |
Dutpase Inhibitors App 20110021459 - GILBERT; Ian ;   et al. | 2011-01-27 |
Antiviral Nucleosides App 20110015148 - Johansson; Nil-Gunnar ;   et al. | 2011-01-20 |
Compounds useful in the treatment of HIV Grant 7,829,548 - Zhou , et al. November 9, 2 | 2010-11-09 |
Antiviral nucleosides Grant 7,825,239 - Kalyanov , et al. November 2, 2 | 2010-11-02 |
Antiviral methods employing double esters of 2', 3'-dideoxy-3'-fluoroguanosine Grant 7,825,238 - Zhou , et al. November 2, 2 | 2010-11-02 |
HIV protease inhibitors Grant 7,807,677 - Ekegren , et al. October 5, 2 | 2010-10-05 |
DUTPase inhibitors Grant 7,795,270 - Gilbert , et al. September 14, 2 | 2010-09-14 |
Hcv Ns-3 Serine Protease Inhibitors App 20100166706 - Rosenquist; Asa ;   et al. | 2010-07-01 |
Antiviral Nucleosides App 20100130735 - Kalyanov; Genadiy ;   et al. | 2010-05-27 |
Macrocyclic inhibitors of hepatitis C virus Grant 7,700,552 - Wahling , et al. April 20, 2 | 2010-04-20 |
Dutpase Inhibitors App 20100075924 - Gilbert; Ian ;   et al. | 2010-03-25 |
HCV NS-3 serine protease inhibitors Grant 7,671,032 - Rosenquist , et al. March 2, 2 | 2010-03-02 |
Antiviral nucleosides Grant 7,666,856 - Johansson , et al. February 23, 2 | 2010-02-23 |
Hcv Inhibiting Macrocyclic Phenylcarbamates App 20100041728 - Antonov; Dmitry ;   et al. | 2010-02-18 |
HCV NS-3 Serine Protease Inhibitors App 20100003216 - Rosenquist; Asa ;   et al. | 2010-01-07 |
Macrocyclic inhibitors of hepatitis c virus App 20090281140 - Simmen; Kenneth Alan ;   et al. | 2009-11-12 |
Antiviral Formulation App 20090270429 - LARSON; Torbjorn | 2009-10-29 |
HCV NS-3 serine protease inhibitors Grant 7,608,590 - Rosenquist , et al. October 27, 2 | 2009-10-27 |
Dutpase Inhibitors Grant 7,601,702 - Gilbert , et al. October 13, 2 | 2009-10-13 |
(2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides As Metalloproteinase Inhibitors App 20090215846 - Wallberg; Hans ;   et al. | 2009-08-27 |
Non-nucleoside reverse transcriptase inhibitors Grant 7,517,992 - Antonov , et al. April 14, 2 | 2009-04-14 |
Acyclic Nucleoside Derivatives App 20090076041 - ENGELHARDT; Per ;   et al. | 2009-03-19 |
Macrocyclic Inhibitors of Hepatitis C Virus App 20090023758 - Wahling; Horst ;   et al. | 2009-01-22 |
Acyclic nucleoside derivatives Grant 7,432,274 - Engelhardt , et al. October 7, 2 | 2008-10-07 |
Non-nucleoside reverse transcriptase inhibitors Grant 7,405,310 - Lindstrom , et al. July 29, 2 | 2008-07-29 |
Compounds Useful in the Treatment of Hiv App 20080176817 - Zhou; Xiao-Xiong ;   et al. | 2008-07-24 |
Non-Nucleotide Reverse Transcriptase Inhibitors App 20080070951 - Sund; Christian ;   et al. | 2008-03-20 |
Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester Grant 7,223,387 - Lekare May 29, 2 | 2007-05-29 |
Synthesis of acyclic nucleoside derivatives Grant 7,189,849 - Leanna , et al. March 13, 2 | 2007-03-13 |
Antivirals Grant 7,148,243 - Sahlberg , et al. December 12, 2 | 2006-12-12 |
Pharmaceutical combination Grant RE39,264 - Harmenberg , et al. September 5, 2 | 2006-09-05 |
Non-nucleoside reverse transcriptase inhibitors App 20060167055 - Antonov; Dmitry ;   et al. | 2006-07-27 |
Antiviral methods employing double esters of 2', 3'-dideoxy-3'-fluoroguanosine Grant 7,071,173 - Zhou , et al. July 4, 2 | 2006-07-04 |
Antiviral methods employing double esters of 2', 3'-dideoxy-3'-fluoroguanosine App 20060122383 - Zhou; Xiao-Xiong ;   et al. | 2006-06-08 |
Synergistic interaction of abacavir and alovudine App 20060084627 - Mardh; Goran | 2006-04-20 |
Antiviral Methods Employing Double Esters Of 2', 3'-dideoxy-3'-fluoroguanosine App 20060058259 - Zhou; Xiao-Xiong ;   et al. | 2006-03-16 |
Treatment of viral infections using prodrugs of 2',3-dideoxy,3'-fluoroguanosine Grant 6,974,802 - Zhou , et al. December 13, 2 | 2005-12-13 |
Synthesis of acyclic nucleoside derivatives App 20050250795 - Leanna, M. Robert ;   et al. | 2005-11-10 |
Non-nucleoside reverse transcriptase inhibitors App 20050240035 - Lindstrom, Stefan ;   et al. | 2005-10-27 |
Intermediate compounds of non-nucleoside reverse transcriptase inhibitors Grant 6,894,177 - Lindstrom , et al. May 17, 2 | 2005-05-17 |
Synthesis of acyclic nucleoside derivatives Grant 6,878,844 - Leanna , et al. April 12, 2 | 2005-04-12 |
Cysteine protease inhibitors App 20050070598 - Quibell, Martin ;   et al. | 2005-03-31 |
Synthesis of acyclic nucleoside derivatives App 20040248910 - Leanna, M. Robert ;   et al. | 2004-12-09 |
Cysteine protease inhibitors App 20040229915 - Quibell, Martin ;   et al. | 2004-11-18 |
Acyclic nucleoside derivatives App 20040132749 - Engelhardt, Per ;   et al. | 2004-07-08 |
Compounds and methods for inhibition of HIV and related viruses App 20040116418 - Lind, Peter Thomas ;   et al. | 2004-06-17 |
Non-nucleoside reverse transcriptase inhibitors Grant 6,716,850 - Lindstrom , et al. April 6, 2 | 2004-04-06 |
Acyclic nucleoside derivatives Grant 6,703,394 - Engelhardt , et al. March 9, 2 | 2004-03-09 |
Synthesis of acyclic nucleoside derivatives App 20040024214 - Leanna, M. Robert ;   et al. | 2004-02-05 |
Non-nucleoside reverse transcriptase inhibitors App 20030187266 - Lindstrom, Stefan ;   et al. | 2003-10-02 |
Prodrugs App 20030186924 - Zhou, Xiao-Xiong ;   et al. | 2003-10-02 |
Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester App 20030171344 - Lekare, Gunilla | 2003-09-11 |
Synthesis of acyclic nucleoside derivatives Grant 6,613,936 - Leanna , et al. September 2, 2 | 2003-09-02 |
Non-nucleoside reverse transcriptase inhibitors Grant 6,610,714 - Sahlberg , et al. August 26, 2 | 2003-08-26 |
Antivirals App 20030119881 - Salhberg, Christer ;   et al. | 2003-06-26 |
Non-nucleoside Reverse Transcriptase Inhibitors App 20030092743 - Sahlberg, Christer ;   et al. | 2003-05-15 |
Non-nucleoside reverse transcriptase inhibitors App 20030069224 - Lindstrom, Stefan ;   et al. | 2003-04-10 |
Acyclic nucleoside derivatives App 20020188125 - Engelhardt, Per ;   et al. | 2002-12-12 |
Antiviral protease inhibitors Grant 6,489,364 - Classon , et al. December 3, 2 | 2002-12-03 |
Compounds and methods for inhibition of HIV and related viruses App 20020132794 - Lind, Peter Thomas ;   et al. | 2002-09-19 |
Pharmaceutical combination Grant 6,337,324 - Harmenberg , et al. January 8, 2 | 2002-01-08 |
Antiviral protease inhibitors App 20010044547 - Classon, Bjorn ;   et al. | 2001-11-22 |
Antiviral protease inhibitors Grant 6,291,687 - Classon , et al. September 18, 2 | 2001-09-18 |
Acyclic nucleoside derivatives Grant 5,869,493 - Engelhardt , et al. February 9, 1 | 1999-02-09 |
N-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infection Grant 5,849,769 - Lind , et al. December 15, 1 | 1998-12-15 |
Method for inhibition of HIV related viruses Grant 5,593,993 - Morin, Jr. , et al. January 14, 1 | 1997-01-14 |
1-(3'-fluoro-2',3'-dideoxy-.beta.-D-ribofuranosyl)-5-substituted pyrimidine nucleosides Grant 5,506,215 - Johansson , et al. April 9, 1 | 1996-04-09 |
Synthesis of furanosyl compounds useful as intermediates in preparation of nucleoside analogues Grant 5,473,063 - Classon , et al. December 5, 1 | 1995-12-05 |
Anti-retroviral activity of 2',3'-dideoxy-3'-fluoronucleosides Grant 5,446,029 - Eriksson , et al. August 29, 1 | 1995-08-29 |
Pyrimidine intermediates Grant 5,440,040 - Gronowitz August 8, 1 | 1995-08-08 |
Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds Grant 5,215,970 - Datema , et al. June 1, 1 | 1993-06-01 |
Antiviral pharmaceutical composition comprising 5-substituted pyrimidine nucleosides Grant 5,215,971 - Datema , et al. June 1, 1 | 1993-06-01 |
SEC | 0001573866 | Medivir AB/ADR |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.